Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +13 vs. Q4 2023
- Shares held
- 172.8M
- −10.0M (−5.5%) vs. Q4 2023
- Total value
- $417.8M
- +$138.0M (+49.3%) vs. Q4 2023
- New holders
- 33
- 31 more added
- Sold out
- 20
- 31 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 534,184 | $1.28M | 0.00% | −1,098,992−67.3% | Reduced |
| Point72 Asset Management, L.P. | 584,386 | $1.40M | 0.00% | +584,386 | New |
| Wellington Management Group LLP | 686,418 | $1.65M | 0.00% | +686,418 | New |
| Northern Trust Corp | 866,556 | $2.08M | 0.00% | +6,968+0.8% | Added |
| Charles Schwab Investment Management Inc | 881,123 | $2.11M | 0.00% | +16,948+2.0% | Added |
| Cubist Systematic Strategies, LLC | 1,404,928 | $3.37M | 0.04% | +1,404,928 | New |
| Ameriprise Financial Inc | 1,417,950 | $3.40M | 0.00% | −472,250−25.0% | Reduced |
| BVF Inc | 1,686,924 | $4.05M | 0.11% | −22,748,708−93.1% | Reduced |
| Pinnacle Associates Ltd | 1,747,830 | $4.19M | 0.07% | +17,009+1.0% | Added |
| State Street Corp | 1,987,510 | $4.77M | 0.00% | +95,191+5.0% | Added |
| Schonfeld Strategic Advisors LLC | 960,150 | $5.35M | 0.04% | +960,150 | New |
| NEA Management Company, LLC | 2,382,286 | $5.72M | 0.35% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,389,137 | $5.73M | 0.00% | +40,221+1.7% | Added |
| OrbiMed Advisors LLC | 3,542,000 | $8.50M | 0.17% | +3,542,000 | New |
| Vanguard Group Inc | 6,401,225 | $15.4M | 0.00% | +420,854+7.0% | Added |
| BlackRock Inc. | 7,693,277 | $18.5M | 0.00% | +688,124+9.8% | Added |
| FMR LLC | 13,894,062 | $33.3M | 0.00% | +11,617,594+510.3% | Added |
| Artal Group S.A. | 117,553,284 | $282.1M | 7.27% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −412,175−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −359,210−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −323,968−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −282,467−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −103,144−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −54,248−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −54,532−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −47,101−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −38,268−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −32,119−100.0% | Sold out |
| Rpo LLC | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −24,500−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −16,522−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −16,054−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,400−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −14,018−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| JNBA Financial Advisors | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |